cholest-5-ene-3,4-diol has been researched along with fluconazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kerksiek, A; Lötsch, J; Lütjohann, D; Oertel, BG; Stellaard, F | 1 |
1 trial(s) available for cholest-5-ene-3,4-diol and fluconazole
Article | Year |
---|---|
Serum 4β-hydroxycholesterol increases during fluconazole treatment.
Topics: Adult; Age Factors; Antifungal Agents; Bile Acids and Salts; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Female; Fluconazole; Humans; Hydroxycholesterols; Lanosterol; Lipid Metabolism; Male; Prospective Studies; Sex Factors; Sterols; Young Adult | 2021 |